WBR0087: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) Created page with "{{WBRQuestion |QuestionAuthor=Ogheneochuko Ajari MB.BS, MS |ExamType=USMLE Step 1 |MainCategory=Biochemistry, Genetics |SubCategory=Neurology |MainCategory=Biochemistry, Genet..." |
Ochuko Ajari (talk | contribs) No edit summary |
||
Line 23: | Line 23: | ||
|Explanation=The patient in this vignette has Huntington’s disease. It is an example of | |Explanation=The patient in this vignette has Huntington’s disease. It is an example of anticipation where the severity of the disease worsens or age of onset of disease is earlier in succeeding generations. Symptoms manifest in affected individuals between the ages of 20 and 50. It is a trinucleotide repeat disorder (CAG)n with the gene located on chromosome 4. Findings include depression, progressive dementia, choreiform movements, caudate atrophy and decreased levels of GABA and Ach in the brain. | ||
|AnswerA=Loss of heterozygosity | |AnswerA=Loss of heterozygosity | ||
|AnswerAExp=An example loss of heterozygosity is retinoblastoma. If there is an inheritance or development of a mutation in a tumor suppressor gene, the complementary allele must be deleted/mutated before cancer develops. | |AnswerAExp=An example loss of heterozygosity is retinoblastoma. If there is an inheritance or development of a mutation in a tumor suppressor gene, the complementary allele must be deleted/mutated before cancer develops. | ||
Line 33: | Line 33: | ||
|AnswerDExp=Anticipation is exhibited by Huntington disease, where the severity of the disease worsens, or age of onset of disease is earlier in succeeding generations | |AnswerDExp=Anticipation is exhibited by Huntington disease, where the severity of the disease worsens, or age of onset of disease is earlier in succeeding generations | ||
|AnswerE=Pleitropy | |AnswerE=Pleitropy | ||
|AnswerEExp=Pleitropy is seen in | |AnswerEExp=Pleitropy is seen in phenylketonuria where one gene has greater than one effect on an individual’s phenotype. | ||
|RightAnswer=D | |RightAnswer=D | ||
|Approved=Yes | |Approved=Yes | ||
}} | }} |
Revision as of 05:00, 8 August 2013
Author | PageAuthor::Ogheneochuko Ajari MB.BS, MS |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Biochemistry, MainCategory::Genetics |
Sub Category | SubCategory::Neurology |
Prompt | [[Prompt::A 56-year old man presents to the physicians office with a history of difficulty with swallowing, involuntary jerky movements of the hands, progressive loss of speech and memory. His father died of similar symptoms and his symptoms is said to be worse than his father’s. This condition is an example of which of the following?]] |
Answer A | AnswerA::Loss of heterozygosity |
Answer A Explanation | AnswerAExp::An example loss of heterozygosity is retinoblastoma. If there is an inheritance or development of a mutation in a tumor suppressor gene, the complementary allele must be deleted/mutated before cancer develops. |
Answer B | AnswerB::Locus heterogeneity |
Answer B Explanation | AnswerBExp::Locus heterogeneity is exhibited by Marfan’s syndrome, MEN 2B and homocystinuria. Mutations at different loci produce the same phenotype. |
Answer C | AnswerC::Genomic imprinting |
Answer C Explanation | AnswerCExp::Genomic imprinting is seen in Prader-Willi syndrome and Angelman syndrome where the differences in phenotype depend on the origin of the mutation whether it is paternal or maternal. |
Answer D | AnswerD::Anticipation |
Answer D Explanation | AnswerDExp::Anticipation is exhibited by Huntington disease, where the severity of the disease worsens, or age of onset of disease is earlier in succeeding generations |
Answer E | AnswerE::Pleitropy |
Answer E Explanation | AnswerEExp::Pleitropy is seen in phenylketonuria where one gene has greater than one effect on an individual’s phenotype. |
Right Answer | RightAnswer::D |
Explanation | [[Explanation::The patient in this vignette has Huntington’s disease. It is an example of anticipation where the severity of the disease worsens or age of onset of disease is earlier in succeeding generations. Symptoms manifest in affected individuals between the ages of 20 and 50. It is a trinucleotide repeat disorder (CAG)n with the gene located on chromosome 4. Findings include depression, progressive dementia, choreiform movements, caudate atrophy and decreased levels of GABA and Ach in the brain. Educational Objective: |
Approved | Approved::Yes |
Keyword | |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |